Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 657 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Silvio E. Inzucchi,Richard M. Bergenstal,John B. Buse,Michaela Diamant,Ele Ferrannini,Michael Nauck,Anne L. Peters,Apostolos Tsapas,Richard Wender,David R. Matthews
Diabetologia.2015;58(3)429
[DOI]
2Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’
Agata Ptaszynska,Samuel M. Cohen,Edward M. Messing,Timothy P. Reilly,Eva Johnsson,Kristina Johnsson
Diabetes Therapy.2015;6(3)357
[DOI]
3Diabetes drugs and the incidence of solid cancers: a survey of the current evidence
Marco Tuccori,Irma Convertino,Maria Teresa Galiulo,Alessandra Marino,Alice Capogrosso-Sansone,Corrado Blandizzi
Expert Opinion on Drug Safety.2017;16(10)1133
[DOI]
4Pioglitazone use and risk of bladder cancer: a systematic literature review and meta-analysis of observational studies
Juha Mehtälä,Houssem Khanfir,Dimitri Bennett,Yizhou Ye,Pasi Korhonen,Fabian Hoti
Diabetology International.2019;10(1)24
[DOI]
5Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
Elena Filipova,Katya Uzunova,Krassimir Kalinov,Toni Vekov
Diabetes Therapy.2017;8(4)705
[DOI]
6An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug’s effect on cardiovascular disease and non-alcoholic steatohepatitis
Mayer B. Davidson,Deyu Pan
Diabetes Research and Clinical Practice.2018;135(4)102
[DOI]
7Pioglitazone and bladder cancer risk: a systematic review and meta-analysis
Huilin Tang,Weilong Shi,Shuangshuang Fu,Tiansheng Wang,Suodi Zhai,Yiqing Song,Jiali Han
Cancer Medicine.2018;7(4)1070
[DOI]
8Comparison of the diabetes guidelines from the ADA/EASD and the AACE/ACE
Susan Cornell
Journal of the American Pharmacists Association.2017;57(2)261
[DOI]
9Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future
Melissa A. Davidson,Donald R. Mattison,Laurent Azoulay,Daniel Krewski
Critical Reviews in Toxicology.2018;48(1)52
[DOI]
10Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Silvio E. Inzucchi,Richard M. Bergenstal,John B. Buse,Michaela Diamant,Ele Ferrannini,Michael Nauck,Anne L. Peters,Apostolos Tsapas,Richard Wender,David R. Matthews
Diabetes Care.2015;38(1)140
[DOI]
11Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes
E. Erdmann,S. Harding,H. Lam,A. Perez
Diabetes, Obesity and Metabolism.2016;18(3)266
[DOI]
12Development of vascular complications and bladder carcinoma in diabetics using pioglitazone: A five-year Indian review
Saarwaani Vallabhajosyula,Shashaank Vallabhajosyula,Saraschandra Vallabhajosyula,Suma Nair,Asha Kamath,Karthik N. Rao
Medical Journal Armed Forces India.2016;72(3)253
[DOI]
13Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis
Yifeng Xu,Yanxiang Wu,Qin Huang
Archives of Gynecology and Obstetrics.2017;296(4)661
[DOI]
14Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC
Vincenza Ciaramella,Ferdinando Carlo Sasso,Raimondo Di Liello,Carminia Maria Della Corte,Giusi Barra,Giuseppe Viscardi,Giovanna Esposito,Francesca Sparano,Teresa Troiani,Erika Martinelli,Michele Orditura,Ferdinando De Vita,Fortunato Ciardiello,Floriana Morgillo
Journal of Experimental & Clinical Cancer Research.2019;38(1)661
[DOI]
15Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes
Hua Qu,Yi Zheng,Yuren Wang,Rui Zhang,Xiongzhong Ruan,Gangyi Yang,Zhenqi Liu,Hongting Zheng
Scientific Reports.2017;7(1)661
[DOI]
16The current role of thiazolidinediones in diabetes management
Christos V. Rizos,Anastazia Kei,Moses S. Elisaf
Archives of Toxicology.2016;90(8)1861
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal